Grifols launches FESILTY fibrinogen concentrate in US for congenital fibrinogen deficiency
The FDA-approved plasma-derived concentrate enables rapid, predictable fibrinogen restoration in paediatric and adult patients — reconstituting in three minutes and offering a purified alternative to cryoprecipitate and fresh frozen plasma